Not applicableLooking for participantsNCT07534007
What this trial is testing
Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies
Who this might be right for
RZV Vaccine (Shingrix ®)
Fondazione IRCCS Policlinico San Matteo di Pavia 150